Partnership of leading scientific service providers enhances offerings for pharmaceutical clients June 25, 2024 –Katy, Texas – ToxStrategies, a best-in-class, multidisciplinary scientific consulting… read more
EpidStrategies’ epidemiologists have collaborated with other researchers on three publications that describe healthcare utilization in 80,000 infants covered by Medicaid, as well as… read more
Dr. Naomi Sacks, Vice President, HEORStrategies, a Division of ToxStrategies LLC, is at the annual meeting of ISPOR (The Professional Society for Health… read more
ToxStrategies LLC, EpidStrategies, a Division of ToxStrategies LLC, and Modality Solutions are pleased to announce 2024 promotions for nearly three-dozen of our scientists, epidemiologists, statisticians,… read more
A recent report by the International Energy Agency (IEA) took inventory of the electrical grid worldwide and found a large gap between investment… read more
HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource use and costs in cardiac arrhythmia patients with paroxysmal supraventricular… read more
Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team… read more
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more